Search results with tag "2018 practice guidance"
Diagnosis, Staging, and Management of Hepatocellular ...
www.aasld.orgHepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Jorge a. Marrero,1 laura M. Kulik,2 Claude B. Sirlin,3 andrew X. Zhu,4 Richard S. Finn,5 Michael M. abecassis,2 lewis R. Roberts,6 and Julie K. Heimbach6 Purpose and Scope This guidance provides a data-supported approach
Ascletis Pharma Inc.
iis.aastocks.comApr 10, 2022 · 1 Lindor K D, Bowlus C L, Boyer J, et al. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases[J]. Hepatology 2019, 69(1): 394-419. DOI: 10.1002/hep.30145. 2 中華醫學會風濕病學分會，原發性膽汁性膽管炎診療規範 (2021)[J]. 中華內科雜誌，2021, 60(8): 709-15.
Primary Biliary Cholangitis: 2018 Practice Guidance from ...
www.aasld.organ autoimmune disease because of its hallmark sero-logic signature, antimitochondrial antibody (AMA), and specific bile duct pathology.(1-4) The etiology of PBC is thought to be due to a combination of genetic risk factors and environmental triggers.(5-7) AMA is a highly disease-specific autoantibody(8)